Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ragweed Pollen Allergy - Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 30 Aug 17

The "Ragweed Pollen Allergy - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Ragweed Pollen Allergy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Ragweed Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ragweed Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Ragweed Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Preclinical and Unknown stages are 1, 4 and 1 respectively.

Key Topics Covered:

  1. Introduction
  2. Ragweed Pollen Allergy - Overview
  3. Ragweed Pollen Allergy - Therapeutics Development
  4. Pipeline Overview
  5. Pipeline by Companies
  6. Products under Development by Companies
  7. Ragweed Pollen Allergy - Therapeutics Assessment
  8. Assessment by Route of Administration
  9. Assessment by Molecule Type
  10. Ragweed Pollen Allergy - Companies Involved in Therapeutics Development
  • ALK-Abello A/S
  • Anergis SA
  • ASIT Biotech SA
  • Astellas Pharma Inc
  • Biomay AG

For more information about this report visit

View source version on

Business Wire

Last updated on: 30/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.